MPM
JAZZ icon

Meritage Portfolio Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Meritage Portfolio Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-61,020
Closed -$6.48M – 333
2025
Q2 		$6.48M Sell
61,020
-14,783
-20% -$1.61M 0.41% 65
2025
Q1 		$9.41M Buy
75,803
+9,529
+14% +$1.24M 0.62% 40
2024
Q4 		$8.16M Sell
66,274
-14,333
-18% -$1.69M 0.51% 50
2024
Q3 		$8.98M Sell
80,607
-771
-0.9% -$84.5K 0.55% 40
2024
Q2 		$8.69M Sell
81,378
-1,159
-1% -$127K 0.55% 42
2024
Q1 		$9.94M Sell
82,537
-2,502
-3% -$306K 0.63% 34
2023
Q4 		$10.5M Buy
85,039
+4,727
+6% +$590K 0.69% 29
2023
Q3 		$10.4M Buy
80,312
+2,331
+3% +$311K 0.77% 26
2023
Q2 		$9.67M Sell
77,981
-7,289
-9% -$981K 0.68% 30
2023
Q1 		$12.5M Buy
85,270
+34,987
+70% +$5.18M 0.93% 20
2022
Q4 		$8.01M Buy
+50,283
New +$7.37M 0.63% 39
2018
Q3 		– Sell
-33,564
Closed -$5.78M – 203
2018
Q2 		$5.78M Sell
33,564
-248
-0.7% -$40.5K 0.56% 61
2018
Q1 		$5.11M Buy
+33,812
New +$4.96M 0.49% 83
2016
Q4 		– Sell
-30,225
Closed -$3.67M – 193
2016
Q3 		$3.67M Sell
30,225
-23
-0.1% -$3.1K 0.4% 127
2016
Q2 		$4.27M Buy
+30,248
New +$4.46M 0.48% 107

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Meritage Portfolio Management's JAZZ Position: Q3 2025 in Review

Meritage Portfolio Management sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2025, closing a stake of 61,020 shares — an estimated $6.48M sold.

Meritage Portfolio Management first reported a position in JAZZ in Q2 2016 and held it in 15 quarters. The position peaked at $12.5M in Q1 2023. 503 funds tracked by Wall St. Rank hold JAZZ as of Q3 2025.

  • Meritage Portfolio Management reported no remaining Jazz Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Meritage Portfolio Management sold 61,020 Jazz Pharmaceuticals shares in Q3 2025, an estimated $6.48M.
  • Meritage Portfolio Management first reported a position in Jazz Pharmaceuticals in Q2 2016 and held it in 15 quarters.
  • Meritage Portfolio Management's Jazz Pharmaceuticals position peaked at $12.5M in Q1 2023.
  • 503 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2025.

Based on Meritage Portfolio Management's 13F filing for Q3 2025, filed 28 Oct 2025.